Loading market data...

Congress Probes Sam Altman’s Investments as OpenAI IPO Faces New Scrutiny

Congress Probes Sam Altman’s Investments as OpenAI IPO Faces New Scrutiny

OpenAI’s plans for an initial public offering have run into a new hurdle: Congressional investigators are now looking into Sam Altman’s personal investments. The probe could weigh on the company’s valuation and underscores the expanding regulatory risks facing big tech firms.

The probe into Altman’s investments

Lawmakers have opened an inquiry into the OpenAI chief executive’s financial holdings, according to people familiar with the matter. The investigation is focused on whether Altman’s outside investments — including stakes in startups that do business with OpenAI or operate in related fields — create conflicts of interest. The committee leading the probe hasn’t publicly detailed the scope, but the move signals a deepening wariness in Washington over how tech leaders manage their personal portfolios.

Altman has long been a prolific angel investor, backing companies such as Stripe and Airbnb before they went public. The question now is whether some of those ties overlap with OpenAI’s own strategic partnerships or product roadmaps. Investigators are expected to examine board disclosures and any voting agreements that might give Altman indirect influence over companies that compete with or supply OpenAI.

Impact on IPO valuation

The Congressional scrutiny comes at a delicate moment. OpenAI was widely expected to pursue an IPO that could value the company at well over $80 billion, based on private secondary-market transactions. But a formal investigation — particularly one that raises governance questions — can spook underwriters and institutional investors.

Bankers working on the potential offering say the probe could delay the timeline or force OpenAI to accept a lower price. “Any hint of insider-dealing risk or lack of board independence is a red flag for IPO investors,” one person close to the process said, speaking on condition of anonymity because the talks are private. The company itself has not commented on the investigation or its IPO plans.

The valuation pressure is real. Just last year, the SEC fined another AI startup over misleading disclosures about its CEO’s financial interests. Regulators are watching, and Congress wants answers before billions of dollars change hands.

Broader regulatory risks for tech markets

This isn’t just about one company. The OpenAI probe fits a pattern of lawmakers taking a harder look at how tech founders structure their personal finances. The concern is that concentrated ownership and opaque investment vehicles let executives personally profit from decisions that should benefit all shareholders.

The broader tech IPO market has already cooled, partly because of regulatory uncertainty. If Congress starts digging into founder deals at multiple firms, the chill could spread. Venture capitalists and startup lawyers are watching closely — any new rules on investment disclosure could reshape how early-stage companies are governed.

For now, the committee hasn’t scheduled a public hearing or set a deadline for OpenAI’s response. But the letter has been sent. The company will have to produce documents and possibly sit for testimony. Whether that happens before or after a potential IPO filing remains an open question — and one that investors are already pricing into their models.